Phase II trial of interleukin-12 followed by interferon alfa-2b in patients with metastatic malignant melanoma: Results from CALGB 500001 (Alliance).
      Google Scholar   
Citation:
Cancer Immunol Res
Year:
2026
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
Primary Committee:
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, R01 CA84402, P30 CA16058, 2U01 CA076576-06, K24 CA93670, 1R21 CA92286-01, T32 CA90223-02, T32 GM139784, UG1CA233331, UG1CA233327  
Corr. Author:
 
Authors:
               
Networks:
LAPS-IL057, LAPS-OH007, MUSC   
Study
CALGB-500001
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: